June 17, 2022: Fourth dose of COVID-19 vaccine in general population
The available evidence is limited, an individual benefit is observed after the administration of a fourth dose for the immunosuppressed and chronically ill population, as well as in the population over 50 years of age, where additional protection against hospitalization and death is evidenced. To date, there are no recommendations for the administration of a fourth dose in the general population by expert groups such as SAGE, ACIP, JCVI.